Literature DB >> 24228130

An adult case of systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder with good outcome.

Xiuming Zhang1, Zhaoming Wang, Lijun Wang, Hongtian Yao.   

Abstract

Epstein-Barr virus-positive T/natural killer (NK)-cell lymphoproliferative disorder (EBV+T/NK LPD) encompasses a heterogeneous group of disorders that have a common feature with excessive lymphoid proliferation of mainly T cells and/or NK cells. This disease is rare, predominantly affects children and young adults, and associated with high mortality. Herein, we report a case of EBV+T/NK LPD that occurred in an old woman with good outcome. The patient presented with fever, splenomegaly, and pancytopenia. Computed tomography (CT) scan of the abdomen showed splenomegaly. The clinical impression was a malignant tumor of spleen, so splenectomy was performed. Microscopically, the architecture of the spleen was preserved. The white pulp Malpighian corpuscles were atrophied. The red pulp showed intact sinusoids and pulp cords with increased cellular infiltrate. The proliferating lymphoid cells were mostly small lymphoid cells with minimal or no nuclear atypia, mixed with rare medium-sized or large cells. Immunohistochemical study and in-situ hybridization showed that the EBER-positive lymphoid cells were positive for CD3 and CD56. They were also positive for cytotoxic molecules, such as T-cell restricted intracellular antigen (TIA1), granzyme B. The case exhibited polyclonal rearrangement of T-cell receptor gene (TCR) by polymerase chain reaction (PCR) studies. Without radiotherapy and chemotherapy, the patient is alive and well with no evidence of disease 25 months after surgery.

Entities:  

Keywords:  Epstein-Barr virus; T/natural killer-cell; lymphoproliferative disorder

Mesh:

Substances:

Year:  2013        PMID: 24228130      PMCID: PMC3816837     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease.

Authors:  K Kawa; T Okamura; K Yagi; M Takeuchi; M Nakayama; M Inoue
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

Review 2.  The chronic mononucleosis syndrome.

Authors:  S E Straus
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

3.  Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.

Authors:  Hiroshi Kimura; Yo Hoshino; Shinya Hara; Naomi Sugaya; Jun-Ichi Kawada; Yukiko Shibata; Seiji Kojima; Tetsuro Nagasaka; Kiyotaka Kuzushima; Tsuneo Morishima
Journal:  J Infect Dis       Date:  2005-01-06       Impact factor: 5.226

Review 4.  Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.

Authors:  Motohiko Okano; Keisei Kawa; Hiroshi Kimura; Akihiro Yachie; Hiroshi Wakiguchi; Akihiko Maeda; Shosuke Imai; Shouichi Ohga; Hirokazu Kanegane; Shigeru Tsuchiya; Tomohiro Morio; Masaaki Mori; Shumpei Yokota; Shinsaku Imashuku
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

5.  A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma.

Authors:  H Kanegane; K Bhatia; M Gutierrez; H Kaneda; T Wada; A Yachie; H Seki; T Arai; S Kagimoto; M Okazaki; T Oh-ishi; A Moghaddam; F Wang; G Tosato
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

6.  Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.

Authors:  L Quintanilla-Martinez; S Kumar; F Fend; E Reyes; J Teruya-Feldstein; D W Kingma; L Sorbara; M Raffeld; S E Straus; E S Jaffe
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

7.  Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

Authors:  Y Kasahara; A Yachie; K Takei; C Kanegane; K Okada; K Ohta; H Seki; N Igarashi; K Maruhashi; K Katayama; E Katoh; G Terao; Y Sakiyama; S Koizumi
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  Prognostic factors for chronic active Epstein-Barr virus infection.

Authors:  Hiroshi Kimura; Tsuneo Morishima; Hirokazu Kanegane; Shouichi Ohga; Yo Hoshino; Akihiko Maeda; Shosuke Imai; Motohiko Okano; Tomohiro Morio; Shumpei Yokota; Shigeru Tsuchiya; Akihiro Yachie; Shinsaku Imashuku; Keisei Kawa; Hiroshi Wakiguchi
Journal:  J Infect Dis       Date:  2003-01-28       Impact factor: 5.226

9.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

10.  Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.

Authors:  Keiko Suzuki; Koichi Ohshima; Kennosuke Karube; Junji Suzumiya; Shouichi Ohga; Shigehiko Ishihara; Kazuo Tamura; Masahiro Kikuchi
Journal:  Int J Oncol       Date:  2004-05       Impact factor: 5.650

View more
  1 in total

Review 1.  Systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder: a case report and review of literature.

Authors:  Xia Tan; Xianling Liu; Chunhong Hu; Fuyou Liu; Fang Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.